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This study investigated whether Terminalia catappa L. hydrophilic extract (TCLW) prevents photoaging in human dermal
ﬁbroblasts after exposure to UVB radiation. TCLW exhibited DPPH free radical scavenging activity and protected erythrocytes
against AAPH-induced hemolysis. In the gelatin digestion assay, the rates of collagenase inhibition by TCL methanol extract,
TCLW, and its hydrolysates were greater than 100% at the concentration of 1mg/mL. We found that serial dilutions of TCLW (10–
500μg/mL) inhibited collagenase activity in a dose-dependent manner (82.3% to 101.0%). However, TCLW did not signiﬁcantly
inhibit elastase activity. In addition, TCLW inhibited MMP-1 and MMP-9 protein expression at a concentration of 25μg/mL
and inhibited MMP-3 protein expression at a concentration of 50μg/mL. TCLW also promoted the protein expression of type
I procollagen. We also found that TCLW attenuated the expression of MMP-1, -3, and -9 by inhibiting the phosphorylation of
ERK, JNK, and p38. These ﬁndings suggest that TCLW increases the production of type I procollagen by inhibiting the activity of
MMP-1, -3 and -9, and, therefore, has potential use in anti-aging cosmetics.
1.Introduction
T h el e a v e so fTerminalia catappa L. (Combretaceae) are
commonly used as folk medicine in Southeast Asia to treat
dermatitis and hepatitis [1]. Extracts of the leaves and
bark of the plant have been reported to have chemopre-
ventive [2, 3], antioxidant, and superoxide radical scav-
enger eﬀects [4], anti-HIV reverse transcriptase activity
[5], and hepatoprotective [4] and anti-inﬂammatory eﬀects
[6]. Terminalia catappa extract has also been shown to
decrease the protein expression of MMP-2 and MMP-9
in lung cancer cells [3]. The phytochemicals in this plant
include tannins (punicalagin, punicalin, terﬂavins A and B,
chebulagic acid), ﬂavanoids (isovitexin, vitexin, isoorientin,
rutin) and triterpenoids (ursolic acid and asiatic acid) [7–9].
The hepatoprotective activity of Terminalia catappa extract
has been shown to be due primarily to the superoxide anion
and hydroxyl radical scavenging activity of ursolic acid and
asiatic acid [10].
Wrinkles, laxity, and hyperpigmentation characterize
aging [11]. Skin aging can be divided into two basic
processes, intrinsic, and extrinsic aging. Extrinsic aging is
generally referred to as photoaging due to chronic exposure
to short wavelength UV light (UVB) and is characterized
by severe wrinkling and pigmentary changes, such as solar
lentigo and mottled pigmentation on exposed areas such as
the face, neck, and forearm. The most abundant structural
protein in skin connective tissue is type I collagen, which
is synthesized primarily by ﬁbroblasts and is responsible for
conferring strength and resiliency [12]. Ultraviolet- (UV-)
induced skin damage principally manifests as degradation
of extracellular matrix (ECM) proteins, including type I
collagen, elastin, proteoglycans, and ﬁbronectin [13, 14]. It
has been shown that UV irradiation leads to the formation
of reactive oxygen species (ROS) that activate the mitogen-
activatedprotein(MAP)kinasepathway,whichsubsequently
induces the expression and activation of matrix metallopro-
teinases (MMPs) in human skin in vivo [15, 16]. MMPs
are known to be upexpressed in human ﬁbroblasts within
hours after exposure to UV irradiation and are, therefore,
considered key factors in the photoaging process. Therefore,
agents with the ability to elevate ECM protein levels or2 Evidence-Based Complementary and Alternative Medicine
inhibit the major collagen-degrading enzymes like MMPs
wouldprovetobeusefulinthedevelopmentofeﬀectiveanti-
aging agents.
This study investigated the eﬀects of Terminalia catappa
extract and its hydrolysates on protein expression of MMPs,
elastase, and type I procollagen in human dermal ﬁbroblasts
after exposure to UVB and investigated the mechanism by
which the extract protects against photodamage.
2.MaterialandMethods
2.1. Chemicals. Leaves of Terminalia catappa L. were
harvested in Taichung County, Taiwan. Human foreskin
ﬁbroblasts were obtained from the Bioresource Collection
and Research Center (Hsinchu, Taiwan). Bradford Reagent
was supplied by Bio-Rad Laboratories (CA, USA). Elastase
substrate IV and porcine elastase were purchased from
Calbiochem (San Diego, CA, USA). Coomassie blue R-250,
dibasic sodium phosphate, Igepal CA-630, tris and 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) were purchased from USB (Cleveland, OH, USA).
CollagenasewaspurchasedfromCalbiochem,Merck(Darm-
stadt, Germany). Fetal bovine serum (FBS), penicillin-
streptomycin, trypsin-EDTA, and Dulbecco’s Modiﬁed
Eagle’sMedium(DMEM)werepurchasedfromGibco,Invit-
rogen (Carlsbad, CA, USA). Fluorogenic Peptide Substrate
I was purchased from R&D systems (Wiesbaden, Germany).
Gelatin, agarose, hydrochloric acid, methanol, dimethyl sul-
foxide (DMSO), propylene glycol (PG), doxycycline hyclate,
calcium chloride (CaCl2), 1,1-diphenyl-2-picrylhydrazy
(DPPH) and 2,2
 -azobis (2-methylpropionamidine) dihy-
drochloride (AAPH), and DL-dithiothreitol were purchased
from Sigma-Aldrich Chemicals (St. Louis, MO, USA).
2.2. Preparation of Terminalia catappa L. Extract and
Its Hydrolysates. The dried leaves were ground and then
extracted twice with a 30-fold volume of methanol for
1h by ultrasonication. The supernatant was ﬁltered and
then evaporated to dryness in vaucum to obtain methanol
extract of Terminalia catappa L. (TCLM). The hydrophilic
extract of Terminalia catappa L. (TCLW) was prepared in
the same manner as TCLM except that the solvent was
replaced with water. Acid hydrolysis of TCLW was carried
out at 80
◦C in the presence of 1.2N HCl (2mL) for 30
min and 2.4N HCl (2mL) for 60 min. After hydrolysis, the
solution was partitioned with ethyl acetate (EA). The EA
layer was evaporated to dryness in vaucum to obtain TCLW
hydrolysate (TCLWH). The abbreviations used for and the
hydrolytic conditions of TCLWH are as follows: TCLWH1,
0.6NHClfor0.5h;TCLWH2,1.2NHClfor0.5h;TCLWH3,
0.6N HCl for 1 h; TCLWH4, 1.2N HCl for 1h. The TCLW
extract and TCLW hydrolysates were stored at −20
◦Cb e f o r e
use.
2.3. Total Phenolic Content of TCLW. Total phenolic content
of TCLW was determined by the Folin-Ciocalteu reaction.
TCLW was mixed with 2-fold 10% Folin-Ciocalteu phenol
reagent. The mixture was allowed to stand at room temper-
ature for 5 min and then sodium carbonate (700mM) was
added to the mixture. The resulting blue complex was then
measured at 760nm. Gallic acid was used as a standard for
thecalibrationcurve.Thephenoliccompoundcontentswere
calibrated using the linear equation based on the calibration
curve. The contents of phenolic compounds are expressed as
μg gallic acid equivalent/mg TCL dry weight.
2.4. DPPH Radical Scavenging Activity of TCLW. Reaction
mixtures containing 200μM DPPH (100μL) and serial
dilutions of sample (concentration of sample ranging from
25 to 1000μg/mL) were placed in a 96-well microplate at
room temperature in the dark for 30 min. After incubation,
the absorbance was read at 517nm by an ELISA reader
(Tecan, Grodig, Austria). Ascorbic acid was used as the
positive control. Scavenging activity was determined by the
following equation:
Scavenging eﬀect %
 
capacity to scavenging the DPPH radical
 
=
⎛
⎝
(Acontrol at 517nm−Ablank at 517nm)−
 
Asample at 517nm−Ablank at 517nm
 
(Acontrol at 517nm−Ablank at 517nm)
⎞
⎠×100.
(1)
2.5. Preparation of Erythrocyte Suspensions and Hemolysis
Assay. Whole blood was obtained from male SD rats
via cardiopuncture and collected in an EDTA-containing
tube. The erythrocytes were isolated by centrifugation at
3000×g for 10 min, washed four times with PBS, and
then resuspended to the desired hematocrit level using
the same buﬀer. In order to induce free radical chain
oxidation in the erythrocytes, aqueous peroxyl radicals
were generated by thermal decomposition of AAPH in
oxygen. An erythrocyte suspension at 5% hematocrit was
incubated with PBS (control) or preincubated with TCLW
(10–50μg/mL) at 37
◦C for 30 min, followed by incubation
with or without 25mM AAPH in PBS at pH 7.4. This
reaction mixture was shaken gently while being incubated
for a ﬁxed interval at 37
◦C. A 200-μL aliquot of the reaction
mixture was removed and centrifuged at 3000×g for 2min,
with absorbance of the supernatant determined at 540nm.
Reference values were determined using the same volume
of erythrocytes in a hypotonic buﬀer (5mM phosphate
buﬀer at pH 7.4; 100% hemolysis). The hemolysis percent-
age was calculated using the formula: [(Asample/Acontrol)] ×
100.Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: DPPH radical scavenging activity of TCLW. The TCLW
providedastronginhibitoryeﬀectandinadose-dependentmanner
(25–1000μg/mL) on DPPH scavenging. (n = 4;∗ P<. 05;∗∗ P<
.01;∗∗∗ P<. 001).
2.6. Gelatin Digestion Assay. Agarose solution (1%) was
prepared in collagenase buﬀer (50mM Tris-HCl, 10mM
CaCl2, 0.15M NaCl, pH 7.8) with 0.15% porcine gelatin
(Sigma Aldrich, Cat. G-2500) and allowed to solidify on
plates.VariousconcentrationsofTCLWandTCLWH(10μL)
dissolved in 10% DMSO were incubated with 10μLo f
bacterial collagenase-1 (0.1mg/mL) in 80μL of collagenase
buﬀe rf o r1ha tr o o mt e m p e r a t u r e .D o x y c y c l i n eh y c l a t ew a s
used as positive control. The samples (40μL) were loaded
onto paper disks placed on gelatin-agarose gel and incubated
for 18h at 37
◦C. The degree of gelatin digestion in agarose
gel was visualized by Coomassie Blue staining after removal
of the paper disks. Following destaining, the area of the
light translucent zone over blue background was determined
by a densitometric program (TINA) to estimate gelatinase
activity.
2.7. MMP Activity Assays. Enzyme activity assays were
performed in 50mM tris buﬀer (pH 7.8), 0.15M NaCl,
and 10mM CaCl2. Various concentrations of TCLW and
TCLWH were tested for their ability to digest a synthetic
ﬂuorogenic substrate (a general MMP substrate). Each
concentration of TCLW and TCLWH was incubated with
1μMs u b s t r a t ea t3 7
◦C for 20 h. Fluorescence intensity was
measuredat320nm(excitation)and450nm(emission)with
a ﬂuorescence reader. The rate of collagenase inhibition was
calculated by the following equation:
Inhibition (%) =
 
1 −
(C −D)
(A −B)
 
×100, (2)
where A indicates the absorbance with enzyme but without
sample, B indicates the absorbance without enzyme and
sample, C indicates the absorbance with enzyme and sample,
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Figure 2: The time course inhibition of TCLW on AAPH-induced
lysis of rat erythrocyte. The TCLW provided a strong inhibitory
eﬀect and in a dose-dependent manner (50–500μg/mL) against
erythrocyte hemolysis.
and D indicates the absorbance without enzyme but with
sample.
2.8. Measurement of Elastase Activity. The elastase inhibition
test on TCLW and TCLWH was investigated using elastase
derived from porcine pancreas. Elastase (500U) was dis-
solvedin5mLof10mMtrisbuﬀer solution (pH 6.0) and
5mg elastase substrate IV was dissolved in 5mL of 100mM
tris buﬀer solution (pH 8.0). To measure elastase activity,
100μL of 100mM tris buﬀer solution (pH 8.0), 25μLo f
elastase substrate IV solution, 50μL of sample solution, and
25μL of elastase solution were dispensed into each well
of a 96-well plate and then preincubated for 20 min at
room temperature. The elastase activity was quantiﬁed by
measuring light absorbance at 405nm using a microplate
reader (Tecan, Grodig, Austria). Each assay was carried out
in triplicate.
The inhibition rate of elastase was calculated by the
following equation:
Inhibition (%) =
 
1 −
(C −D)
(A − B)
 
×100, (3)
where A indicates the absorbance with enzyme but without
sample, B indicates the absorbance without enzyme and
sample, C indicates the absorbance with enzyme and sample,
and D indicates the absorbance without enzyme but with
sample.
2.9. Cell Culture. Human foreskin ﬁbroblasts (Hs68) were
obtained from neonatal foreskins and cultured in DMEM
supplemented with 10% fetal bovine serum, 100U/mL
penicillin, and 100U/mL streptomycin in a humidiﬁed4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: The inhibition of Terminalia catappa L. water extract, methanol extract, and its hydrolysates on collagenase activity. (a) Terminalia
catappa L. water extract (TCLW), and methanol extract (TCLM), (b) Terminalia catappa L. water extract (TCLW) and its hydrolysates
1mg/mL, and (c) Terminalia catappa L. water extract (TCLW) 0.05–1mg/mL (H1: hydrolyzed by 0.6N HCl for 30 min; H2: 1.2N HCl for
30 min; H3: hydrolyzed by 0.6N HCl for 60 min; H4: 1.2N HCl for 60 min) (positive control, DC 100: doxycycline 100μg/mL; control: dd
water) (n = 4;∗ P<. 05;∗∗ P<. 01;∗∗∗ P<. 001).
atmosphere of 5% CO2 at 37
◦C. Hs68 cells were plated at
80%–90% conﬂuence in all experiments.
2.10. MTT Assay for Cell Viability. The ﬁbroblasts were
plated at a density of 104 cells/well in a 96-well plate and
thentreatedwithvariousconcentrationsofextractsdissolved
in DMSO (<0.1%) for 24h. Mitochondrial dehydrogenase
activity, which can be used as an index of cell viability,
was assessed using the MTT assay as previously described
[17].Viabilitywasquantiﬁedbymeasuringtheabsorbanceat
570nm using a microplate reader (Tecan, Grodig, Austria).
2.11. UV Irradiation. Cells were cultured until 80% con-
ﬂuent, washed twice with phosphate-buﬀered saline (PBS),
and then exposed to UVB irradiation in PBS (302nm, CL-
1000M, UVP, USA). In our previous study, the dose ofEvidence-Based Complementary and Alternative Medicine 5
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Figure 4: The inhibition rate (%) of TCLW on bacterial collagenase
activity using ﬂuorometric assay. (n = 4;∗∗ P<. 01).
80mJ/cm2 UVB irradiation was determined to induce MMP
without being cytotoxic (data not shown). Subsequently,
cells were incubated for 24h in 37
◦C in a humidiﬁed
atmosphere of 5%CO2 in serum-free DMEM containing
various concentrations of TCLW and TCLWH.
2.12. Western Blotting Analysis. Western blotting assay was
performed using whole cell lysates prepared from Hs68 cells
at a density of 5 × 105 cells. Cells were harvested and
homogenized with lysis buﬀer containing 10mM Na3VO4,
10 mg/mL leupeptin, 10mg/mL PMSF and RIPA, and then
the lysates were subjected to centrifugation at 12000 ×gf o r
10min. All reactions were performed in triplicate. Protein
concentration in the culture medium was measured using
Bradford reagent (Bio-Rad, Hercules, CA, USA) with bovine
serum albumin as the standard. Cell lysates containing equal
amounts of total protein were separated by electrophoresis
on SDS-polyacrylamide gel and then transferred to a PVDF
membrane (Hybond ECL, Amersham Pharmacia Biotech
Inc., Piscataway, NJ, USA). Nonspeciﬁc binding was blocked
with nonfat milk in TBST ((10mM Tris-HCl, pH 7.5,
150mM NaCl) containing 0.05% Tween 20). The membrane
wasincubatedwithgoatpolyclonalantibodiesagainstMMP-
1 (1:500) and type I procollagen (1: 500), and mouse poly-
clonal antibodies against MMP-3 (1: 500), MMP-9 (1: 500),
ERK(1:500),JNK(1:500),p38(1:500),p-ERK(1:500),p-
JNK (1:500) and p-p38 (1:500) (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA). Anti-immunoglobulin G-
horseradish peroxidase (Santa Cruz Biotechnology Inc.) was
used as the secondary antibody. Immunoreactive proteins
were detected with the ECL Western blotting detection
system (Fujiﬁlm, LAS-4000, Japan). Signal strengths were
quantiﬁed using a densitometric program (multi Gauge
V2.2).
2.13. Statistical Analysis. Each experiment was performed
in triplicate and all data are presented as mean ± SD.
Signiﬁcant diﬀerences between groups were analyzed by
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Figure 5: The inhibition rate of TCLW on porcine elastase. (n = 4).
ANOVA followed by the Scheﬀe’s test. A P value <.05 was
considered signiﬁcant.
3. Results
3.1. Extraction Yield and Total Phenolic Content of TCLW.
The extraction yield of TCLW was 22.5% and that of TCLM
was 13.5%. The total phenolic content, expressed as μg gallic
acid equivalents (GAE) per mg of dry weight (TCL), was
102.0 ±0.2μg GAE/mg.
3.2. Scavenging of DPPH Radicals. Figure 1 shows the free
radical scavenging activity of TCLW (25–1000μg/mL) and
ascorbic acid (25mg/mL); TCLW exhibited excellent DPPH
radical scavenging activity. Our results indicated that DPPH
radical scavenging activity of TCLW at 25μg/mL (95.8 ±
0.3%) was similar to that of ascorbic acid at an equal
concentration (96.2 ±0.2%).
3.3. Erythrocyte Hemolysis Assay. The inﬂuence of TCLW
(10–500μg/mL) on in vitro erythrocyte hemolysis was
examined by incubating rat erythrocytes in the presence
of 25mM AAPH as an initiator of oxidation. TCLW (50–
500μg/mL) exhibited a strong dose-dependent inhibitory
eﬀect against erythrocyte hemolysis (Figure 2).
3.4. TCLW and TCLWH Inhibited Bacterial Collagenase-1.
For visual investigation of the inhibitory eﬀect of TCLM,
TCLW, and TCLWH on MMPs, an indirect assay was devel-
oped using bacterial collagenase-1. Following incubation
of bacterial collagenase-1 with various concentrations of
TCLW and TCLWH, the inhibition of enzyme activity was
compared with enzyme activity of the control. As Figure 3(a)
shown,DMSOasthecontrolgroupreactionwiththereagent
exhibited the highest gelatinolytic activity in the discrete
zone; the doxycycline, a well-known MMP inhibitor, was
the positive control resulting clear zone. The collagenase-1
inhibition of TCLW and TCLM was similar to doxycycline.
Asshownin Figure 3(b), the rates of collagenase-1inhibition6 Evidence-Based Complementary and Alternative Medicine
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Figure 6:EﬀectofTCLWontheUVB-inducedexpressionofMMP-
1, 3, 9, and type I procollagen in human ﬁbroblasts. (n = 4;∗ P<
.05;∗∗ P<. 01;∗∗∗ P<. 001).
were 94.3 ±0.8% for doxycycline (100μg/mL), 100.7 ±0.9%
for TCLW (1000μg/mL), 101.4±0.5% for TCLWH1, 102.2±
0.4% for TCLWH2, 105.8 ± 3.4% for TCLWH3, and 106.7 ±
3.5% for TCLWH4. The rates for collagenase-1 inhibition for
various concentrations (50–1000μg/mL) of TCLW ranged
from 81.9 ± 0.7% to 100.7 ± 0.7%. In addition, TCLW
inhibited gelatinolytic activity in a dose-dependent manner
(Figure 3(c)).
3.5. TCLW Inhibited Bacterial Collagenase-1. Fluorescence-
conjugated gelatin was used to measure the inhibitory eﬀect
of TCLW on bacterial collagenase-1 protein expression.
Fluorescence-conjugated substrate was incubated with bac-
terial collagenase-1 for 20h in the presence of diﬀerent
concentrations of TCLW or doxycycline hyclate (positive
control) at 37
◦C. TCLW exhibited a signiﬁcant inhibitory
eﬀect on bacterial collagenase-1; the inhibition rate was
>95%ofthecontrolatconcentrations ≥50μg/mL(Figure 4).
3.6. The Eﬀect of TCLW on Elastase Activity. This assay
measuresthesynthesisandactivityofelastaseincellsexposed
to TCLW. As shown in Figure 5, TCLW (10–500μg/mL) did
not have a signiﬁcant eﬀect on elastase activity.
3.7. TCLW Inhibited the Protein Expression of MMPs. UVB
irradiation of untreated Hs68 cells resulted in a 1.5-fold
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Figure 7: Eﬀect of TCLW on the UVB-induced expression of MAP
kinases in human ﬁbroblasts. (n = 4;∗ P<. 05;∗∗ P<. 01).
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Figure 8: Cell viability of TCLW on human ﬁbroblasts. (n =
4;∗∗ P<. 01;∗∗∗ P<. 001).
increase in MMP-1 expression, a 2.2-fold increase in MMP-
3 expression, and a 2.3-fold increase in MMP-9 expression
relative to control levels. TCLW treatment (25–100μg/mL),
however, suppressed the UVB-induced upregulation of
MMPs (Figure 6). TCLW at concentrations of 25μg/mL
and higher led to a signiﬁcant decrease in MMP-1 and -9
expression to basal level. TCLW treatment at concentrationsEvidence-Based Complementary and Alternative Medicine 7
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Figure 9: The mechanisms of TCLW on UVB-induced photodamage.
of 50μg/mL and higher signiﬁcantly inhibited MMP-3
expression (Figure 6).
3.8.TCLWUpregulatesTypeIProcollagenExpression. Fibrob-
lasts were treated with TCLW (5–100μg/mL) for 24h
after exposure to UVB (80mJ/cm2). TCLW treatment
(≥50μg/mL) led to a signiﬁcant increase in the expression
of type I procollagen (Figure 6).
3.9. Eﬀe c to fT C L Wo nM A PK i n a s eE x p r e s s i o n . UVB irradia-
tion of untreated Hs68 cells resulted in a 1.4-fold increase in
p-ERK expression, a 1.2-fold increase in p-JNK expression,
and a 1.5-fold increase in phosphorylated p38 relative to
control levels. TCLW treatment (5–100μg/mL), however,
signiﬁcantly inhibited the UVB-induced overexpression of
those MAP kinases. P-ERK was suppressed to the basal level
at 10μg/mL TCLW, p-JNK was suppressed to the basal level
at 25μg/mL TCLW, and phosphorylated p38 was suppressed
to the basal level at 5μg/mL TCLW (Figure 7).
3.10. Eﬀect of TCLW on Cell Viability. Hs68 cells were treated
with various concentrations of TCLW (5–200μg/mL) and
cell viability was measured. As shown in Figure 8, TCLW did
not exhibit cytotoxic eﬀects on the proliferation of cells (cell
viability >90% of control). In addition, TCLW promoted cell
proliferation in a dose-dependent manner.
4. Discussion
Aging is a complex phenomenon that is modulated by
multiple factors, including genetics, life style, and exposure
to sunlight and pollutants. UV radiation produces ROS,
which activate MAPkinase pathway to induce the expression
and activation of MMPs that degrade extracellular matrix
proteins including type I collagen, elastin, and glycosamino-
glycans in skin [18, 19].
It has been shown that Moringa oleifera extract, which
has a total phenolic content of 52.5μg GAE/mg, has potent
DPPH scavenging activity [20]. In addition, Fraxinus chinen-
sis extract scavenges UVA-induced DPPH free radicals and
inhibits MMP-1 mRNA and protein expression in human
skin ﬁbroblasts [21]. Sorbus commixta Hedl, a compound
with a high total phenolic content, exhibits free radical
scavenging eﬀect and decreases MMP-1 mRNA expression
[22]. Terminalia catappa L. leaves are rich in polyphenol
antioxidants. In addition, studies have shown that the
antioxidant activities of polyphenols reduce the risk of skin
diseases [23]. We speculate that TCLW can protect against
oxidative stress-induced photodamage because of its high
total phenolic content (102μg GAE/mg), DPPH free radical
scavenging activity, as well as its ability to prevent AAPH-
induced hemolysis and activate MMP.
UV stimulates collagenase expression, which causes
matrix protein degradation and, subsequently, skin pho-
toaging [24, 25]. Collagenase-1 (MMP-1) degrades collagen,
gelatin, and proteoglycan link protein, and collagenase-3
(MMP-3) is involved in several MMP activation cascades
including activation of MMP-1 [26]. Agents that inhibit
collagenase activity would be ideal candidates for the pre-
vention or treatment of photoaging. Botanical extracts have
been reported to suppress collagenase activity. For example,
Viscum coloratum inhibits collagenase release [27]a n d
Morinda citrifolia inhibits elastase and tyrosinase activities
[28]. In addition, xanthorrhizol, a sesquiterpenoid isolated
from ethyl acetate extract of Curcuma xanthorrhiza, inhibits
UVB-induced MMP-1 expression and increases the level of8 Evidence-Based Complementary and Alternative Medicine
type I procollagen in human ﬁbroblasts [29]. Erythrodiol-3-
acetate from Spiraea japonica stem extract has been shown to
upregulate type I procollagen expression in ﬁbroblasts after
exposure to UVB irradiation [30]. Furthermore, Magnolia
obovata extract (150μg/mL) and Polypodium leucotomos
(50μg / m L )h a v eb e e nr e p o r t e dt oa t t e n u a t eM M P - 1e x p r e s -
sion [31, 32]. We found that TCLW (25μg/mL) inhibited
MMP-1, -3 and -9 expression, a ﬁnding consistent with that
reported by Yang et al. [33].
MAP kinases are upstream regulators of MMP activity
[34–36]. It has been reported that green tea polyphenol,
epigallocatechin-3-gallate (EGCG) inhibits the expression of
MMPs by attenuating the phosphorylation of ASK-1 and
MAPkinase pathway [37]. In addition, treatment of UV-
irradiated cells with 4-hydroxypanduratin A, isolated from
Kaempferia pandurata Roxb, leads to decreased MMP-1
expression by inhibiting c-Fos and c-Jun phosphorylation
and MAP kinase pathway activation [38]. In this study,
TCLW signiﬁcantly inhibited UVB-induced p-ERK, p-JNK,
and phosphorylated p38 expression at doses of 10, 25,
and 5μg/mL, respectively. It has been shown that UV
irradiation induces p38 activation [34]. Furthermore, it has
been reported that UVB irradiation induces ERK, JNK,
and p38 activation via production of ROS [39, 40]. Green
tea polyphenol, EGCG, suppresses UV-induced oxygen
stress-mediated MAP kinase phosphorylation pathway [41].
The ﬂavonoid, ﬁsetin inhibits UV-induced MAP kinase
expression and NF-κB signal transduction [42, 43]. In our
study, TCLW exhibited potent antioxidant activity, inhibited
the expression of MAP kinases and MMPs, and activated
type I procollagen. Those ﬁndings indicate that TCLW
is a potential agent for the treatment or prevention of
photodamage. TCLW hampered the activation of MAPKs,
and, therefore, may downregulate the down stream proteins
c-Fos and c-Jun, as well as the transcription factor AP-1 and
protooncogenes involved in photodamage (Figure 9). The
eﬀects of TCLW on transcription of c-Fos, c-Jun, and AP-1
need further study.
5. Conclusions
TCLW inhibits UVB-induced ROS, phosphorylation of p38,
JNK, and ERK, and attenuates the expression of MMP-1, -3,
-9, thereby elevating type I procollagen synthesis. TCLW,
therefore, could be a potential antiphotodamage agent.
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